sponsored
PatientsVille.com Logo

PatientsVille

Magnevist Nephrogenic Fibrosing Dermopathy Side Effects

Magnevist Nephrogenic Fibrosing Dermopathy Side Effect Reports


The following Magnevist Nephrogenic Fibrosing Dermopathy side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Nephrogenic Fibrosing Dermopathy, can occur, and what you can do about them.

A side effect could appear soon after you start Magnevist or it might take time to develop.



Nephrogenic Fibrosing Dermopathy, Progressive Massive Fibrosis

This Nephrogenic Fibrosing Dermopathy side effect was reported by a consumer or non-health professional from UNITED STATES. A 24-year-old patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Magnevist (dosage: Unk, 1 Dose), which was started on Feb 01, 2004. Concurrently used drugs: NA. When starting to take Magnevist the consumer reported the following symptoms:
  • Nephrogenic Fibrosing Dermopathy
  • Progressive Massive Fibrosis
These side effects may potentially be related to Magnevist.
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy Magnevist side effect was reported by a physician from UNITED STATES on Jun 15, 2007. A male , 62 years of age, weighting 163.1 lb, was treated with Magnevist. The patient presented the following health conditions:
  • Nephrogenic Fibrosing Dermopathy
. Magnevist dosage: 20 Ml, 1 Dose. Additional drugs used at the same time: NA.
Nephrogenic Fibrosing Dermopathy

This is a Magnevist side effect report of a 15-year-old patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Magnevist (dosage:10 Ml, 1 Dose, start time: Sep 01, 2004), combined with:
  • Omniscan (Unk, 1 Dose)
  • Omniscan (8 Ml, 1 Dose)
  • Omniscan (8.8 Ml, 1 Dose)
  • Omniscan (Unk, 1 Dose)
  • Omniscan (Unk, 1 Dose)
  • Omniscan (Unk, 1 Dose)
  • Omniscan (8 Ml, 1 Dose)
  • Optimark (4 Ml, 1 Dose)
, and developed a serious reaction and a Nephrogenic Fibrosing Dermopathy side effect. The patient presented with:
  • Nephrogenic Fibrosing Dermopathy
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnevist treatment in patients suffering from NA, resulting in Nephrogenic Fibrosing Dermopathy.

Nephrogenic Fibrosing Dermopathy

A 51-year-old female patient (weight: NA) from UNITED KINGDOM with the following symptoms: NA started Magnevist treatment (dosage: 40 Ml, 1 Dose) on Sep 05, 2006. Soon after starting Magnevist treatment, the consumer experienced several side effects, including:
  • Nephrogenic Fibrosing Dermopathy
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Magnevist side effects, such as Nephrogenic Fibrosing Dermopathy.
Nephrogenic Fibrosing Dermopathy, Restrictive Pulmonary Disease

A patient from UNITED STATES was prescribed and started Magnevist on Jun 15, 2007. Patient felt the following Magnevist side effects: nephrogenic fibrosing dermopathy, restrictive pulmonary disease Additional patient health information: male , 72 years of age, weighting 198.0 lb, The consumer reported the following symptoms: . Magnevist dosage: Unk, 1 Dose. Concurrently used drugs: NA.
Coronary Artery Thrombosis, Nephrogenic Fibrosing Dermopathy

This report suggests a potential Magnevist Nephrogenic Fibrosing Dermopathy side effect(s) that can have serious consequences. A 82-year-old patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): nuclear magnetic resonance imaging brain and used Magnevist (dosage: 20 Ml, 1 Dose) starting Aug 27, 2001. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Coronary Artery Thrombosis
  • Nephrogenic Fibrosing Dermopathy
Drugs used concurrently:
  • Lopressor (50 Mg, 3x/day)
  • Allopurinol (100 Mg, 1x/day)
  • Zocor (10 Mg, 1x/day)
  • Levothyroxine Sodium (25 A?g, 1x/day)
  • Nephrocaps (1 Cap(s), 1x/day)
  • Insulin (Sliding Scale)
  • Nortriptyline Hcl (10 Unk, Bed T.)
  • Glipizide (2.5 Mg, Qam)
Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Nephrogenic Fibrosing Dermopathy, may still occur.
Nephrogenic Fibrosing Dermopathy, Pulmonary Oedema

An adverse event was reported by a physician on Jun 12, 2007 by a Female taking Magnevist (dosage: Unk, 1 Dose) was diagnosed with and. Location: UNITED STATES , 80 years of age, weighting 138.0 lb, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Magnevist side effects: nephrogenic fibrosing dermopathy, pulmonary oedema. Additional medications/treatments:
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy problem was reported by a physician from SPAIN. A 51-year-old patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Dec 12, 2006 a consumer started treatment with Magnevist (dosage: 40 Ml, 1 Dose). The following drugs/medications were being taken at the same time:
  • Mastical
  • Zyloric ^faes^
  • Aranesp
  • Manidipine Hydrochloride
  • Irbesartan
  • Lymetel
  • Omeprazole
  • Seguril
When commencing Magnevist, the patient experienced the following unwanted symptoms /side effects:
  • Nephrogenic Fibrosing Dermopathy
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Nephrogenic Fibrosing Dermopathy, may become evident only after a product is in use by the general population.
Nephrogenic Fibrosing Dermopathy

This is a Magnevist side effect report of a 42-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Magnevist (dosage: 20 Ml, 1 Dose) starting Jun 08, 2006. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Nephrogenic Fibrosing Dermopathy
This opens a possibility that Magnevist could cause Nephrogenic Fibrosing Dermopathy and that some patients may be more susceptible.
Excoriation, Loss Of Consciousness, Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy side effect was reported by a physician from UNITED STATES on Jun 01, 2007. A patient from UNITED STATES , 64 years of age, weighting 209.4 lb, was diagnosed with and was treated with Magnevist. Directly after treatment started, patient experienced the unwanted or unexpected Magnevist side effects: excoriation, loss of consciousness, nephrogenic fibrosing dermopathy. Magnevist dosage: Unk, 1 Dose. These side effects may potentially be related to Magnevist.
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy side effect was reported by a physician from ITALY. A 75-year-old patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Magnevist (dosage: Unk, 1 Dose), which was started on May 18, 2006. Concurrently used drugs: NA. When starting to take Magnevist the consumer reported the following symptoms:
  • Nephrogenic Fibrosing Dermopathy
These side effects may potentially be related to Magnevist.
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy Magnevist side effect was reported by a physician from UNITED STATES on Jun 01, 2007. A Female , 52 years of age, was treated with Magnevist. The patient presented the following health conditions:
  • Nephrogenic Fibrosing Dermopathy
. Magnevist dosage: 20 Ml, 1 Dose. Additional drugs used at the same time: NA.
Nephrogenic Fibrosing Dermopathy

This is a Magnevist side effect report of a 55-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: nuclear magnetic resonance imaging, who was treated with Magnevist (dosage:20 Ml, 1 Dose, start time: Apr 24, 2005), combined with: NA., and developed a serious reaction and a Nephrogenic Fibrosing Dermopathy side effect. The patient presented with:
  • Nephrogenic Fibrosing Dermopathy
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnevist treatment in female patients suffering from nuclear magnetic resonance imaging, resulting in Nephrogenic Fibrosing Dermopathy.
Nephrogenic Fibrosing Dermopathy

A 75-year-old patient (weight: NA) from GERMANY with the following symptoms: NA started Magnevist treatment (dosage: Unk, 1 Dose) on May 18, 2006. Soon after starting Magnevist treatment, the consumer experienced several side effects, including:
  • Nephrogenic Fibrosing Dermopathy
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Magnevist side effects, such as Nephrogenic Fibrosing Dermopathy.
Nephrogenic Fibrosing Dermopathy

A patient from UNITED STATES was prescribed and started Magnevist on May 31, 2007. After Magnevist was administered, patient encountered several Magnevist side effects: nephrogenic fibrosing dermopathy Additional patient health information: male , 42 years of age, The consumer reported the following symptoms: . Magnevist dosage: 20 Ml, 1 Dose. Concurrently used drugs: NA.
Blood Pressure Increased, Nephrogenic Fibrosing Dermopathy, Oedema Peripheral, Pruritus, Superior Vena Caval Occlusion, Thrombosis, Vein Disorder

This report suggests a potential Magnevist Nephrogenic Fibrosing Dermopathy side effect(s) that can have serious consequences. A 33-year-old patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): angiogram and used Magnevist (dosage: Unk, 1 Dose) starting Jul 23, 2006. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Blood Pressure Increased
  • Nephrogenic Fibrosing Dermopathy
  • Oedema Peripheral
  • Pruritus
  • Superior Vena Caval Occlusion
  • Thrombosis
  • Vein Disorder
Drugs used concurrently:NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Nephrogenic Fibrosing Dermopathy, may still occur.
Nephrogenic Fibrosing Dermopathy

An adverse event was reported by a physician on May 31, 2007 by a male taking Magnevist (dosage: 40 Ml, 1 Dose) . Location: UNITED STATES , 36 years of age, patient began experiencing various side effects, including: Patient felt the following Magnevist side effects: nephrogenic fibrosing dermopathy. Additional medications/treatments:
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy problem was reported by a health professional from UNITED STATES. A 43-year-old patient (weight: NA) was diagnosed with the following medical condition(s): nuclear magnetic resonance imaging.On Mar 09, 2007 a consumer started treatment with Magnevist (dosage: 20 Ml, 1 Dose). The following drugs/medications were being taken at the same time: NA. When commencing Magnevist, the patient experienced the following unwanted symptoms /side effects:
  • Nephrogenic Fibrosing Dermopathy
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Nephrogenic Fibrosing Dermopathy, may become evident only after a product is in use by the general population.
Nephrogenic Fibrosing Dermopathy

This is a Magnevist side effect report of a 30-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: nuclear magnetic resonance imaging and was treated with Magnevist (dosage: 10 Ml, 1 Dose) starting Apr 27, 2004. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Nephrogenic Fibrosing Dermopathy
This opens a possibility that Magnevist could cause Nephrogenic Fibrosing Dermopathy and that some female patients may be more susceptible.
Nephrogenic Fibrosing Dermopathy

This Nephrogenic Fibrosing Dermopathy side effect was reported by a physician from UNITED STATES on May 31, 2007. A female patient from UNITED STATES , 72 years of age, was treated with Magnevist. Patient felt the following Magnevist side effects: nephrogenic fibrosing dermopathy. Magnevist dosage: 20 Ml, 1 Dose. These side effects may potentially be related to Magnevist.
1 of 6 

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Magnevist Nephrogenic Fibrosing Dermopathy Causes and Reviews


We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.


Magnevist Nephrogenic Fibrosing Dermopathy Reviews

No reviews submitted yet, check in later.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Magnevist Side Effects

Nephrogenic Systemic Fibrosis (920)
Urticaria (813)
Nausea (573)
Pruritus (551)
Dyspnoea (517)
Vomiting (511)
Erythema (507)
Anxiety (443)
Joint Range Of Motion Decreased (438)
Pain (425)
Oedema Peripheral (387)
Mobility Decreased (370)
Emotional Distress (361)
Fibrosis (341)
Arthralgia (330)
Deformity (265)
Joint Stiffness (253)
Injury (243)
Joint Contracture (240)
Sneezing (232)
Gait Disturbance (232)
Dry Skin (225)
Asthenia (223)
Anhedonia (222)
Pain In Extremity (207)
Burning Sensation (197)
Rash (192)
Musculoskeletal Stiffness (191)
Cough (187)
Hypoaesthesia (182)
Extremity Contracture (180)
Skin Induration (165)
Dizziness (162)
Muscular Weakness (160)
Skin Hypertrophy (156)
Fatigue (144)
Throat Irritation (144)
Skin Tightness (135)
Nephrogenic Fibrosing Dermopathy (131)
Chest Discomfort (131)
Feeling Hot (126)
Nasal Congestion (125)
Anaphylactic Reaction (114)
Throat Tightness (113)
Flushing (112)
Hyperhidrosis (102)
Convulsion (100)
Back Pain (99)
Chest Pain (98)
Skin Discolouration (98)

➢ More

Magnevist Common Side Effects

If you experienced any harmful or unwanted effects of Mucinex, please share your experience. This could help to raise awareness about Mucinex side effects, identify uknown risks and inform health professionals and patients taking Mucinex.

Examples: headache, dizziness

The most commonly reported Magnevist side effects (click to view or check a box to report):

Nephrogenic Systemic Fibrosis (920)
Urticaria (813)
Nausea (573)
Pruritus (551)
Dyspnoea (517)
Vomiting (511)
Erythema (507)
Anxiety (443)
Joint Range Of Motion Decreased (438)
Pain (425)
Oedema Peripheral (387)
Mobility Decreased (370)
Emotional Distress (361)
Fibrosis (341)
Arthralgia (330)
Deformity (265)
Joint Stiffness (253)
Injury (243)
Joint Contracture (240)
Gait Disturbance (232)

➢ More


Don't miss out on new findings! Check the latest Clinical Research and Recruiting Clinical Trials for Your Health Condition

Check out clinical research studies for common conditions: Fatigue, Dizziness, Orajel, Viagra, Diarrhea , Promethazine, Penacillamine, Seretide, Tramadol, Eosinophilic Fasciitis, Colgate, Didanosine (videx Ec), Propranolol, Tizanadine, Ralivia, Propofol, Gw679769, CLIP APPLIER SMALL, Sotoger, Basen, Diprospan, Lapatinib, ANGIODYNAMICS SMART PORT CT, Repronex, Amifostine, Ketonal Duo, Botox, Paxil, ARIS TOT MESH, Glucagen, Cardiolite, Detensiel, Neostigmine, ENDOSCOPE, NEUROLOGICAL, Danatrol, Crinone, Campto, Roaccutan, Monistat3, Iletin, Cromoptic, Isordil, Mabthera, Foliamin, Bilol

Discuss Magnevist Side Effects

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!